You are on page 1of 1

More Creat

C rren Iss e Frida , Oc ober 7, 2022 RSS FEED

Subscribe in a reader
A c c F d L e R fW
D ab F F -E de P c S bscribe ia email

Patients with first-episode psychosis have a Enter your Email

lower risk of work disability during periods


when taking antipsychotics compared with
periods not taking the medications, a report S bscribe!
published Thursday in The Ame ican J nal
f P chia has found. The data—obtained Weekl Ne sle er
from multiple Swedish databases on patients
aged 16 to 45 who received a first nonaffective psychosis diagnosis—revealed
that long-acting injectable (LAI) formulations may be particularly beneficial
with regard to work disability.

“Reducing work disability can reduce indirect costs of schizophrenia and


Ne s From C rren Iss e
enable patients to be involved in gainful employment and to experience a
- Special Report: Bipolar Disorder II sense of accomplishment, a structure for daily routine, and the possibility of
—Frequently Neglected, belonging to a social group through interactions with coworkers,” wrote Marco
Misdiagnosed Solmi, M.D., Ph.D., of the University of Ottawa and colleagues.

- Rare Neuropsychiatric Variants The study included 21,551 people (average age 29; 61% male) who received
Present in 1% of Individuals
a first nonaffective psychosis diagnosis (including schizophrenia, schizotypal,
- APA’s Annnual Meeting and View delusional, and other non-mood psychotic disorders). The researchers
Program compared work disability outcomes (sickness absence or disability pension)
during periods when these patients were taking antipsychotics with periods
when they were not between 2006 and 2016.
Blog Archi e
Nearly 46% of first-episode patients had work disability during the average

► 2023 (44) length of follow-up of 4.8 years, according to the researchers. The risk of
2022 (246) work disability was 35% lower during antipsychotic use compared with no use
► by the same individuals.
► December (21)

► November (19) “The lowest adjusted hazard ratios emerged for long-acting injectable
October (20) antipsychotics (aHR=0.46), oral aripiprazole (aHR=0.68), and oral olanzapine
Naltrexone May Reduce Binge (aHR=0.68),” Solmi and colleagues wrote. “Long-acting injectables were
Drinking in Sexual and... associated with lower risk than olanzapine, the most commonly used oral
Study Highlights Children Most antipsychotic (aHR=0.68).”
Likely to Be Taken ...
Females With Autism More The researchers noted, “The mechanism through which antipsychotics are
Likely Than Males to Deve... associated with better work functioning is currently unknown. We hypothesize
Behavioral Therapy Plus that antipsychotics exert their action at least partially via their effect on
Naltrexone-Bupropion positive symptoms, enabling psychosocial rehabilitation and/or return to
Combi... functionality in a sizable subgroup of patients.”
Neurological Complications
Associated With Worse O... For related information, see the P chia ic Ne articles “LAI Antipsychotics
AACAP Publishes Practice Beat Oral Meds for Preventing Relapse, Hospitalization” and “Study Calculates
Guidelines on Child and A... Disability Caused by Schizophrenia.”
Risk of Mental Illness, Pain
Disorders Higher in C... Image: iS ck/P ck-S di )

ECT May Be Superior to


Ketamine for Reducing
Sever...

Experts Offer Six Steps for


Increasing Universal A... Don't miss out! To learn about newly posted articles in P chia ic Ne ,
Trauma-Informed OB Care Can please sign up here.
Help Pregnant Women, T...
APA Announces Candidates for
2023 Election Follo P chia ic Ne on T itter!
Adverse Childhood
Experiences During
Pandemic Take...
P ed b P chia ic Ne A e a 1:27 PM
Follow-up Care of Youth After
Psychiatric Emergenc...

You might also like